To include your compound in the COVID-19 Resource Center, submit it here.

Combretastatin A4 Prodrug: OXGN began a dose-ranging U.S. Phase Ib trial of combretastatin in combination with carboplatin in up to 35 patients. OXGN said the h

OxiGene Inc. (OXGN; SSE:OXGN), Boston, Mass.
Product: Combretastatin A4 Prodrug

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE